PPP1R15B

PPP1R15B

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">PPP1R15B (CReP)</th></tr>
<tr><td><b>Full Name</b></td><td>Protein Phosphatase 1 Regulatory Subunit 15B</td></tr>
<tr><td><b>Symbol</b></td><td>PPP1R15B</td></tr>
<tr><td><b>Alias</b></td><td>CReP, Constitutive Repressor of eIF2α Phosphorylation</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>1q21.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>84919</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000167524</td></tr>
<tr><td><b>UniProt ID</b></td><td>Q9H0X4</td></tr>
<tr><td><b>Associated Diseases</b></td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Prion disease</td></tr>
</table>
</div>

Overview

PPP1R15B (also known as CReP, Constitutive Repressor of eIF2α Phosphorylation) is a regulatory subunit of protein phosphatase 1 that dephosphorylates eIF2α. It plays a key role in the integrated stress response (ISR), which is a cellular pathway that coordinates adaptation to various types of stress[@novoa2001]. CReP is one of two eIF2α phosphatases in mammals (the other being GADD34), and it provides basal repression of the ISR under non-stress conditions. Variants in PPP1R15B have been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions where endoplasmic reticulum stress and the integrated stress response play important roles in disease pathogenesis.

Summary

PPP1R15B

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4ea;">PPP1R15B (CReP)</th></tr>
<tr><td><b>Full Name</b></td><td>Protein Phosphatase 1 Regulatory Subunit 15B</td></tr>
<tr><td><b>Symbol</b></td><td>PPP1R15B</td></tr>
<tr><td><b>Alias</b></td><td>CReP, Constitutive Repressor of eIF2α Phosphorylation</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>1q21.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>84919</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000167524</td></tr>
<tr><td><b>UniProt ID</b></td><td>Q9H0X4</td></tr>
<tr><td><b>Associated Diseases</b></td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Prion disease</td></tr>
</table>
</div>

Overview

PPP1R15B (also known as CReP, Constitutive Repressor of eIF2α Phosphorylation) is a regulatory subunit of protein phosphatase 1 that dephosphorylates eIF2α. It plays a key role in the integrated stress response (ISR), which is a cellular pathway that coordinates adaptation to various types of stress[@novoa2001]. CReP is one of two eIF2α phosphatases in mammals (the other being GADD34), and it provides basal repression of the ISR under non-stress conditions. Variants in PPP1R15B have been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions where endoplasmic reticulum stress and the integrated stress response play important roles in disease pathogenesis.

Summary

PPP1R15B encodes CReP (Constitutive Repressor of eIF2α Phosphorylation), a regulatory subunit of protein phosphatase 1 that specifically dephosphorylates eIF2α. This protein is a critical component of the integrated stress response (ISR), which adapts cellular function to various stresses including ER stress, oxidative stress, and amino acid deprivation[@novoa2001]. Under basal conditions, CReP maintains low levels of eIF2α phosphorylation, allowing normal protein synthesis. Upon stress, eIF2α kinases (PERK, GCN2, PKR, HRI) phosphorylate eIF2α, globally reducing translation while selectively upregulating stress-response genes. CReP then acts as a feedback mechanism to dephosphorylate eIF2α and restore protein synthesis when stress is resolved. Dysregulation of this pathway has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders[@baird2012][@sokka2019].

Normal Function

eIF2α Phosphatase Complex

PPP1R15B forms a regulatory subunit complex with protein phosphatase 1 (PP1)[@novoa2001]. This complex specifically targets the alpha subunit of eukaryotic initiation factor 2 (eIF2α):

• CReP protein: 684 amino acids, contains PP1-binding motif
• PP1 catalytic subunit: Provides the phosphatase activity
• Substrate specificity: The CReP regulatory subunit directs PP1 to dephosphorylate specifically eIF2α

The Integrated Stress Response

CReP in the Stress Response

Physiological Roles

CReP plays several critical physiological roles[@halloran2013]:

Disease Associations

Alzheimer's Disease

The integrated stress response is heavily dysregulated in Alzheimer's disease brains[@baird2012][@ma2013]:

• eIF2α hyperphosphorylation: Elevated levels of phosphorylated eIF2α in AD brain
• PERK overactivation: The PERK-eIF2α axis is chronically activated in AD
• GADD34 imbalance: Altered ratio of GADD34 to CReP contributes to dysregulation
• Protein synthesis deficits: Reduced global translation may impair synaptic plasticity

Parkinson's Disease

ER stress is a key mechanism in dopaminergic neuron death in Parkinson's disease[@sokka2019][@song2021]:

• ER stress in PD: Dopaminergic neurons are particularly vulnerable to ER stress
• CReP protective role: CReP may help protect neurons by reducing eIF2α phosphorylation
• UPR dysregulation: The unfolded protein response is perturbed in PD
• Therapeutic targeting: Modulating eIF2α phosphatases may have therapeutic benefit

Amyotrophic Lateral Sclerosis (ALS)

• ER stress in ALS: Motor neuron degeneration involves ER stress pathways
• eIF2α signaling: Altered eIF2α phosphorylation in ALS models and patients
• CReP potential: Enhancing CReP activity may protect motor neurons

Prion Disease

• eIF2α dysfunction: Prion diseases show profound translation dysregulation
• PERK activation: Early PERK activation in prion disease models
• Therapeutic targeting: eIF2α phosphatases as therapeutic targets

Molecular Mechanisms

CReP vs. GADD34

CReP and GADD34 are the two eIF2α phosphatases in mammals with distinct properties[@bjornberg2021]:

| Feature | CReP | GADD34 |
|---------|------|--------|
| Expression | Constitutive | Stress-induced |
| Basal activity | Yes | Minimal |
| Stress induction | No | Strong |
| Knockout phenotype | Embryonic lethal | Viable |

eIF2α Phosphorylation in Neurodegeneration

Pathophysiology in Detail

ER Stress and Neuronal Vulnerability

The endoplasmic reticulum (ER) is a critical organelle for protein folding, calcium homeostasis, and lipid biosynthesis. Neurons are particularly vulnerable to ER stress due to their high protein synthesis rates, complex morphology, and post-mitotic nature[@hoozemans2014]. Several factors contribute to ER stress in neurodegenerative diseases:

CReP plays a critical role in managing ER stress by maintaining eIF2α phosphorylation levels. When CReP is dysregulated, the adaptive UPR transitions to a pro-apoptotic response.

The PERK-eIF2α-ATF4 Axis

The PERK-eIF2α-ATF4 pathway is a central component of the integrated stress response that becomes dysregulated in neurodegeneration[@shacham2019]:

In chronic neurodegeneration, this pathway becomes persistently activated, leading to:

• Sustained translation repression
• Synaptic protein loss
• Pro-apoptotic gene expression
• Metabolic dysregulation

Synaptic Dysfunction

The integrated stress response directly impacts synaptic function[@abdel2018]:

Protein Homeostasis in Neurodegeneration

CReP is essential for maintaining protein homeostasis in neurons[@bjornberg2021]:

Therapeutic Strategies

Targeting eIF2α Phosphorylation

Modulating eIF2α phosphorylation is a promising therapeutic strategy[@schwartz2020][@li2020]:

| Strategy | Approach | Status |
|----------|----------|--------|
| PERK inhibitors | Small molecules inhibiting PERK kinase | Preclinical |
| ISRIB | eIF2α phosphorylation inhibitor | Preclinical |
| GADD34 inhibitors | Reduce eIF2α dephosphorylation | Research |
| CReP modulators | Enhance CReP activity | Research |

Pharmacological Approaches

Gene Therapy Approaches

Interaction Network

Protein-Protein Interactions

| Partner | Interaction Type | Function |
|---------|-----------------|----------|
| PPP1R15A (GADD34) | Homolog | Alternative eIF2α phosphatase |
| PPP1CA | Catalytic subunit | Phosphatase activity |
| PPP1R1A | Regulatory subunit | PP1 regulatory family |
| eIF2S1 (eIF2α) | Substrate | Target of dephosphorylation |
| HSPA5 (BiP) | Co-chaperone | ER stress sensing |
| DNAJB11 | Co-chapterone | ER folding assistance |

Signaling Pathways

Clinical Implications

Biomarkers

Diagnostic Approaches

Future Directions

Research Priorities

Unanswered Questions

• Why are neurons particularly vulnerable to ISR dysregulation?
• How does CReP dysfunction contribute to specific disease features?
• Can ISR modulation prevent neurodegeneration?
• What determines the balance between adaptive and apoptotic UPR?

Expression Patterns

PPP1R15B is expressed in most tissues with specific patterns:

• Brain: Neurons and glia, particularly in cortex, hippocampus
• Ubiquitous expression: All cell types require basal eIF2α phosphatase activity
• Regulation: Expression is relatively constitutive, not strongly induced by stress
• Subcellular localization: Predominantly cytoplasmic

Genetics and Variants

Known Variants

• Missense variants: Some associated with neurodegenerative disease risk
• Regulatory variants: May affect expression levels
• Splice variants: May alter splicing patterns

Therapeutic Approaches

Targeting the ISR

Several therapeutic strategies are being explored[@schwartz2020]:

Drug Development

• ISRIB: Shows promise in preclinical models
• PERK inhibitors: In clinical development for AD and other diseases
• GADD34 inhibitors: Might be protective in acute stress

Gene Therapy

• CReP overexpression: Could enhance eIF2α phosphatase activity
• RNAi against GADD34: Shift balance toward CReP activity

Interacting Proteins

• PP1 (Protein Phosphatase 1): Catalytic subunit of the phosphatase complex
• eIF2α: Substrate for dephosphorylation
• ATF4: Transcription factor regulated by eIF2α phosphorylation
• CHOP: Pro-apoptotic transcription factor induced by ER stress
• GADD34: Alternative eIF2α phosphatase (stress-induced)

Animal Models

Knockout Models

• Ppp1r15b^-/- mice: Embryonic lethal, demonstrating essential function
• Conditional knockouts: Tissue-specific deletion reveals functions in specific cell types

Transgenic Models

• CReP overexpression: Protected against ER stress in some models
• CReP deficiency: Exacerbated neurodegeneration in disease models

Key Publications

Related Conditions

• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)
• [Amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Prion disease](/diseases/prion-disease)
• [Endoplasmic reticulum stress](/mechanisms/er-stress-pathway)
• [Integrated stress response](/mechanisms/integrated-stress-response)

See Also

• [Genes Directory](/genes/)
• [Proteins Directory](/proteins/)
• [Integrated stress response mechanisms](/mechanisms/integrated-stress-response)
• [Unfolded protein response](/mechanisms/endoplasmic-reticulum-stress)
• [ER stress pathways](/mechanisms/er-stress-pathway)

External Links

• [NCBI Gene: 84919](https://www.ncbi.nlm.nih.gov/gene/84919)
• [Ensembl: ENSG00000167524](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167524)
• [UniProt: Q9H0X4](https://www.uniprot.org/uniprot/Q9H0X4)
• [OMIM: 617069](https://www.omim.org/entry/617069)

References

CReP in Synaptic Function

Synaptic Plasticity

CReP/eIF2α phosphatase plays critical roles in synaptic plasticity:

Long-term Potentiation:

• eIF2α phosphorylation state modulates LTP
• CReP activity affects LTP maintenance
• ATF4 translation in synaptic plasticity
• Synaptic tagging and capture mechanisms

• eIF2α in LTD induction
• Protein synthesis-dependent LTD
• Memory erasure mechanisms
• Metabotropic glutamate receptor signaling

Local Translation

CReP regulates local protein synthesis at synapses:

Synaptic Protein Synthesis:

• Local translation requirement for synaptic plasticity
• eIF2α phosphorylation blocks translation initiation
• CReP maintains basal translation capacity
• Activity-dependent protein synthesis

• Synaptic tag formation mechanisms
• Capture of plasticity-related proteins
• CReP in tag establishment and maintenance

CReP in Glial Function

Astrocyte ER Stress

CReP in astrocyte biology:

Astrocytic ER Homeostasis:

• CReP expression in astrocytes
• ER stress response in reactive astrocytes
• Astrocyte support of neuronal function

• Astrocytic CReP in neuron support
• Metabolic coupling mechanisms
• Calcium signaling modulation

Microglial Function

CReP modulates microglial activity:

Inflammatory Response:

• eIF2α phosphorylation in microglia
• CReP in cytokine production
• Neuroinflammation modulation
• Anti-inflammatory therapies targeting ISR

CReP in Aging

Age-Related Changes

CReP function during aging:

Expression Changes:

• Altered CReP expression with age
• eIF2α phosphorylation increases with age
• Age-related ER stress accumulation

• Reduced protein synthesis capacity
• Impaired stress response
• Synaptic dysfunction with age

Age-Related Diseases

CReP in age-related neurodegeneration:

• Alzheimer's disease progression
• Parkinson's disease vulnerability
• Sarcopenia and muscle aging
• Cognitive decline mechanisms

CReP Therapeutic Approaches

Small Molecule Modulators

PERK Inhibitors:

• GSK2656157: PERK inhibitor in clinical trials
• AZD0328: Selective PERK inhibitor
• Combined approaches with other UPR targets

• ISRIB: eIF2α-B ternary complex stabilizer
• ISRIB analogs with improved properties
• Blood-brain barrier penetration

• CReP activators under development
• GADD34 inhibitors for stress conditions
• PP1-targeted approaches

Gene Therapy

Viral Vector Delivery:

• AAV-CreP expression vectors
• Neuron-specific promoters
• Regulated expression systems

• CReP knockout strategies
• GADD34 deletion for stress conditions
• Allele-specific editing

Combination Therapies

Multi-target Approaches:

• PERK inhibitor with antioxidant
• ISR modulation with autophagy enhancers
• UPR targeting with neuroprotective compounds

CReP in Other Diseases

Metabolic Disorders

Diabetes:

• CReP in pancreatic beta cell function
• ER stress in diabetes pathogenesis
• Therapeutic targeting potential

• CReP in adipocyte function
• Metabolic stress response
• Energy homeostasis

Cardiovascular Disease

Cardiac Function:

• CReP in cardiac ER stress
• Ischemia-reperfusion injury
• Heart failure mechanisms

• Endothelial CReP in vascular stress
• Atherosclerosis progression
• Blood pressure regulation

Cancer

Tumor Biology:

• CReP in cancer cell survival
• UPR in tumor development
• Therapeutic targeting in oncology

Animal Models of CReP

Knockout Studies

Global Knockout:

• Ppp1r15b^-/- embryonic lethality
• Severe ER stress phenotype
• Essential developmental function

• Neuron-specific deletion
• Astrocyte-specific deletion
• Tissue-specific phenotypes

Transgenic Models

Overexpression:

• CReP overexpression protection
• Conditional expression systems
• Disease model applications

• CReP phosphorylation mutants
• GADD34-CReP balance models
• Human variant knockin

Research Techniques for CReP

Molecular Biology

Gene Expression:

• qPCR for PPP1R15B mRNA
• Reporter constructs
• Single-cell RNA-seq

• Western blot for CReP
• Phospho-eIF2α antibodies
• PP1 complex identification

Imaging

Live Cell Imaging:

• eIF2α phosphorylation sensors
• Translation reporters
• ER stress indicators

• Immunohistochemistry
• In situ hybridization
• Electron microscopy

Functional Studies

Cellular Assays:

• eIF2α phosphatase activity
• Protein synthesis rates
• Stress response markers

• Behavioral testing
• Neurophysiological analysis
• Biochemical characterization

CReP as a Biomarker

Diagnostic Potential

Disease Biomarkers:

• eIF2α phosphorylation as marker
• CReP expression in patient samples
• ATF4 as ISR activation marker

Prognostic Value

Disease Progression:

• Biomarker correlation with progression
• Treatment response prediction
• Survival correlation

Therapeutic Monitoring

Target Engagement:

• eIF2α phosphorylation changes
• Translation rate monitoring
• Stress marker normalization